Trade DBVT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
DBV Technologies S.A. American Depositary Shares (DBVT) is trading at US$13.64, down 5.34% today as of Aug 28, 12:22 EDT. The company has a market capitalisation of US$914.41M. Over the past 52 weeks, DBVT has traded between US$8.70 and US$26.19. On Syfe you can trade DBVT with $0 commission and add it to your watchlist.
| Previous close | US$14.41 |
|---|---|
| Market cap | US$914.41M |
| 52-week range | US$8.70 – US$26.19 |
| Volume | 130.92K |
| Exchange | US |
Add to Watchlist
Set Price Alert
DBV Technologies S.A. American Depositary Shares
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.
Year: 2014
DBV Technologies Q2 Net Loss Narrows
Jul 16, 8:14 PM · MT Newswires
DBV Expects Viaskin Peanut Patch BLA Submission in Q3 After FDA Feedback
Jun 29, 8:48 PM · MT Newswires
DBV Technologies Screens First Subject in Phase 2 Study of Peanut Allergy Patch Trial
Jun 3, 8:47 AM · MT Newswires
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
Mar 9, 3:30 PM · MT Newswires
Stay on top of DBVT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
